Status | Study |
Not yet recruiting |
Study Name: Oxytocin, Alcohol Craving, and Intimate Partner Aggression Condition: Alcohol Use Date: 2017-02-03 Interventions: Drug: Oxytocin 40 IU oxytocin |
Not yet recruiting |
Study Name: Nivolumab With or Without Varlilumab in Treating Patients With Relapsed or Refractory Aggressive B-cell Lymphomas Condition: Activated B-Cell-Like Diffuse Large B-Cell Lymphoma ALK-Positive Large B-Cell Lymphoma Date: 2017-01-31 Interventions: Other: Laboratory Biomarker Analysis |
Recruiting |
Study Name: Study of Venetoclax Plus DA-EPOCH-R for the Treatment of Aggressive B-Cell Lymphomas Condition: Diffuse Large B-Cell Lymphoma High Grade B-Cell Lymphoma Date: 2017-01-27 Interventions: Drug: Venetoclax Venetoclax wi |
Recruiting |
Study Name: Transcranial Direct Current Stimulation in Offenders Condition: Aggression Risk-Taking Antiso Date: 2017-01-26 Interventions: Device: Transcranial direct current stimulation |
Recruiting |
Study Name: Dendritic Cell Therapy, Cryosurgery, and Pembrolizumab in Treating Patients With Non-Hodgkin Lymphoma Condition: Aggressive Non-Hodgkin Lymphoma Indolent Non-Hodgkin Lymphoma Date: 2017-01-26 Interventions: Procedure: Cryosurgery Undergo |
Enrolling by invitation |
Study Name: Aggressive Incidents in Medical Settings Study Condition: Aggression Date: 2017-01-25 |
Recruiting |
Study Name: Enamel Matrix Proteins in the Treatment of Intrabony Defects in Patients With Aggressive and Chronic Periodontitis Condition: Aggressive Periodontitis Date: 2017-01-16 Interventions: Biological: Enamel Matrix Proteins |
Not yet recruiting |
Study Name: Nab-paclitaxel/Rituximab-coated Nanoparticle AR160 in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma Condition: Aggressive Non-Hodgkin Lymphoma CD20 Positive Date: 2016-12-22 Interventions: Other: Laboratory Biomarker Analysis |
Completed |
Study Name: Effects of Er,Cr:YSGG, Diode Lasers on GCF Cytokines Levels Condition: Aggressive Periodontitis Date: 2016-12-21 Interventions: Procedure: SRP+940±15 nm diode laser |
Recruiting |
Study Name: Study to Examine the Safety and Efficacy of Pimavanserin for the Treatment of Agitation and Aggression in Alzheimer's Disease (SERENE) Condition: Agitation and Aggression in Alzheimer's Disease Date: 2016-12-12 Interventions: Drug: Pimavanserin 34 mg Pimav |